KETA $KETA tight share structure with only $30 OS, tiny mc of $13M considering Ketamine is on track to record the highest CAGR of the psychedelic drugs market (forecasted to reach a value of $6.33 Billion by 2026)
It has proven efficacy in higher doses as an anaesthetic and can induce changes in cognition and mood at lower doses
$KETA operates a consultative virtual clinic and tele-health platform connecting patients to prospective a US physician who evaluate and prescribe treatment programs of low-dose, oral ketamine medication
the remote diagnostic platform increases patient access and patient monitoring.
$KETA.C @ $0.43, trading over 3X avg volume today
https://www.globenewswire.com/news-release/2021/10/04/2307610/28124/en/The-Psychedelic-Drugs-Market-Global-Industry-Analysis-2018-2020-Growth-Trends-and-Market-Forecast-2021-2026.html